MedPlus Health Services Ltd Share Price

Overview

MedPlus Health Services Ltd share price is currently ₹655.59, up by ₹1.43 (0.22%) from its previous closing price of ₹654.16. The share price has declined -3.73% over the past month and declined -22.16% over the past year. The stock's 52-week low and high are ₹639.82 and ₹1,005.95, respectively. MedPlus Health Services Ltd has a market capitalisation of ₹ 8,120.00 Cr. The share price was last updated on 09 Sep 2026, 09:07 AM IST.

MedPlus Health Services Ltd
MedPlus Health Services Ltd
MEDPLUS
 0.00
 1.43
0.22%
Healthcare
 0.00(%)1D

Updated: 09 Sep 2026, 09:07:06 am IST

Market Data

Open Price

 655.59

Prev. Close

 654.16
 655.59

Day Low

 655.59

Day High

 639.82

52 Week Low

 1,005.95

52 Week High

HealthcareRetailing
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

37.36

Sector PE

42.03

PB Ratio

4.00

Sector PB

5.73

EPS

17.55

Dividend Yield

0.00

Today's Volume

75.796 K

5 Day Avg. Volume

159.610 K

PEG Ratio

0.82

Market Cap.

₹ 8,120.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
ICICI Prudential Conservative Hybrid Fund - Regular Plan - Growth-
2.51 Lac
(100%)
iSIF Equity Long-Short Fund - Regular Plan - Growth32.41 k
-
(100%)
iSIF Equity Ex-Top 100 Long-Short Fund - Regular Plan - Growth3.68 Lac
-
(100%)
Unifi Flexi Cap Fund - Regular Plan - Growth22.44 k
-
(100%)
SBI ELSS Tax Saver Fund - Regular Plan - IDCW40.68 Lac
-
(100%)

About MedPlus Health Services Ltd 👋

MedPlus Health Services Limited is an India-based company. The Company is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. It operates through three segments: Retail, Diagnostics, and Others. The Retail segment is engaged in trading pharmaceuticals and general items through its retail stores and online platform. The Diagnostics segment includes diagnostic services, pathological services, and laboratory testing services. The other segment includes the insurance broking business. Its products include Pharmaceutical and wellness products and Fast-moving consumer goods (FMCG). Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its e-commerce portals include MedPlus Mart, MedPlus Lens, and MedPlus Labs.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Saurab Jain

Saurab Jain

24 Aug • 9:27 PM · SEBI-Registered Analyst

MedPlus Retail Pharmacy Network Supports Growth

MEDPLUS
MedPlus Health Services is a key player in India’s organised pharmacy retail sector, with a growing store network and presence across medicines, wellness products and diagnostics. Rising healthcare awareness, recurring medicine demand and the shift toward organised retail support its long-term growth potential. Its private-label products can also help improve margins and product mix. However, competition from local pharmacies and online platforms, along with store expansion costs and regulatory changes, remains important to monitor. Overall, MedPlus’ expanding network and integrated healthcare model keep it relevant in India’s growing healthcare-consumption market. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link visit website www dot investmentcure dot com *****

See More
Vipin Dixena

Vipin Dixena

22 Jul • 3:29 PM · SEBI-Registered Analyst

Why Did

MEDPLUS
Shares Fall 16%?

MEDPLUS
shares declined nearly 16% after the company reported a 21% year-on-year decline in Q1 net profit, disappointing investors despite continued revenue growth. The decline in profitability was largely attributed to higher operating expenses, investments in store expansion, and pressure on margins. While the company continues to expand its pharmacy network and strengthen its presence in diagnostics, the higher costs impacted earnings during the quarter. The sharp correction reflects concerns over profitability rather than growth. MedPlus continues to benefit from the long-term structural opportunity in India's organized pharmacy market, but investors should closely monitor margin recovery, same-store sales growth, store productivity, and operating leverage over the coming quarters. The market has reacted to weaker earnings, but the long-term investment thesis will depend on whether MedPlus can translate its expansion strategy into stronger profitability while sustaining revenue growth.

See More
Chahat Aggrawal

Chahat Aggrawal

21 Jun • 9:50 PM · SEBI-Registered Analyst

MedPlus Subsidiary Receives Drug License Suspension Order

⚖️

MEDPLUS
disclosed that its subsidiary Optival Health Solutions Private Limited has received a 10-day drug license suspension order from the FDA Maharashtra. The order cites alleged violations under the Drugs and Cosmetics Act, 1940, and pertains to the subsidiary's pharmacy operations.

See More
Pankaj pawar

Pankaj pawar

4 Jun • 8:23 AM · SEBI-Registered Analyst

BHEL

STOCKS IN FOCUS TODAY ##Positive Sentiments • Indian Energy Exchange (IEX) – Power volumes surge across segments • Atlanta Electricals (!ATLANTAA) – LoA from Punjab State Transmission worth ₹285 Cr •

BHEL
– Bags ₹2,000–2,500 Cr order win • Aurobindo Pharma – Biologics manufacturing unit inaugurated • Jain Irrigation – Biochar plant commissioned • Hero MotoCorp – Launches flex-fuel motorcycles • Jeena Sikho Lifecare – Receives NABH accreditation • Texmaco Rail – Strategic partnership with TrinityRail • JBM Auto – Sold 157 e-buses during the month ##Negative Sentiments • Rajesh Exports – SEBI passes interim order • HMA Agro – CEO & MD resigns • MedPlus Health – Drug licence suspended • Steel Strips Wheels – Deputy MD resigns

See More
Naveen Kumar

Naveen Kumar

24 May • 11:58 PM · SEBI-Registered Analyst

MEDPLUS

It is GOOD because Revenue +24% YoY to ₹1,864 cr; PAT +25% YoY to ₹64 cr; EBITDA margin improved to 5.8% from 5.3%. Full-year FY26 PAT +46% to ₹220 cr. Pharmacy retail is in structural growth phase with organized players growing at 20%+. Stock surged 11% post-results. Subsidiary drug license issue in Telangana/Karnataka is a minor setback offset by strong operational momentum. Over 3,000 stores operational now.

See More
PATEL ABHIKUMAR HARESHBHAI

PATEL ABHIKUMAR HARESHBHAI

12 Apr • 1:09 PM · SEBI-Registered Analyst

Daily Index View : SENSEX as on 12/04/2026

1. Market Trend PROBABILITY 🚨 Current Market Trend: Positive 🚀 25% 🔍 Key Level to Watch: 76239 🔄 Current Market Surface: The trend will stay Positive until the market stay above 76239 That’s 1311 points away from the last day Closing Price of 77550 Market is very much up compared to Daily Average True Range, which can be very hard to change on downside on a single day 2. Demand & Supply PROBABILITY Force is Demand & Supply is High 15% Last 3 days market has been flatish compared to ATR, so demand has very strong firepower — it just needs sentiment support 10 Apr 2026 FII Cash-net (Buy/sell) DII Cash- net (BUY/SELL) +672.09 +410.05 3. Reflexivity PROBABILITY First Half is Strongly Suppotive to Bullish Momentum for atlest first Half 10% Last day market rallied more than the 8-day average ATR, so it should keep its momentum intact in the first half 4. Social Proof (Global) PROBABILITY Dow Jones (Last day close) 48185 Dow jones intray rally/Fall- last day -282.82 Dow jones future (live) 48,178 Up/Donw by -238 Hang seng (Live) 25752 Up/Donw from last day clsoe 141 Sentiments: Dow Jones Futures is Trading Negative & HANG SENG Index is trading Flat to Positive -46% Today, global markets are clearly negative, and the Indian market is moderately aligned — bearish bias Top stock to watchout

MEDPLUS

See More

Frequently Asked Questions

What is the share price of MedPlus Health Services Ltd?

What is the market cap of MedPlus Health Services Ltd?

Should I buy MedPlus Health Services Ltd stock now?

What is the 52 week high and low of MedPlus Health Services Ltd?

Is the MedPlus Health Services Ltd stock good to buy?

Is MedPlus Health Services Ltd a good buy for the long term?

Is MedPlus Health Services Ltd overvalued or undervalued?

What is the PE and PB ratio of MedPlus Health Services Ltd?

Start Now